Linc00839 was significantly upregulated both in tamoxifen-resistant breast cancer cells and ADR-resistant breast cancer cells, and the inhibition of Linc00839 enhanced apoptosis induced by paclitaxel by targeting the PI3K/AKT pathway in breast cancer cells [26]. Here, LINC00839 is linked to breast cancer.